Cardiovascular Clinical Study LLC Boston, MA - 02111

Cardiovascular Clinical Study LLC is categorized under Medical Research in Boston, MA and active since 2002.

Cardiovascular Clinical Study LLC was established in 2002, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.

If you are seeking more information, feel free to contact Michael Jarvis at the company’s single location by writing to 860 Washington St 113, Boston, Massachusetts MA 02111 or by phoning (617) 636-4839. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Cardiovascular Clinical Study LLC
Contact Person: Michael Jarvis
Address: 860 Washington St 113, Boston, Massachusetts 02111
Phone Number: (617) 636-4839
Website Address: ccs-trials.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2002
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Medical Research
SIC Code: 8733
NAICS Code: 541720
Share This Business:

Cardiovascular Clinical Study LLC was started in 2002 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Michael Jarvis for inquiries that concern Cardiovascular Clinical Study LLC by calling the company number (617) 636-4839, as your correspondence is most welcome. Additionally, the physical location of the single location of Cardiovascular Clinical Study LLC can be found at the coordinates 42.348634,-71.063844 as well as the street address 860 Washington St 113 in Boston, Massachusetts 02111.

For its online presence, you may visit Cardiovascular Clinical Study LLC’s website at ccs-trials.com and engage with its social media outlets through on Twitter and on Facebook.